These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34532252)

  • 1. High TNFSF13B expression as a predictor of poor prognosis in adrenocortical carcinoma.
    Mao Y; Alimu P; Wang C; Ma W; Zhuo R; Sun F
    Transl Androl Urol; 2021 Aug; 10(8):3275-3285. PubMed ID: 34532252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KIF11 is a potential prognostic biomarker and therapeutic target for adrenocortical carcinoma.
    Zhou Y; Chen X; Li B; Li Y; Zhang B
    Transl Androl Urol; 2023 Apr; 12(4):594-611. PubMed ID: 37181234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microenvironment-related gene TNFSF13B predicts poor prognosis in kidney renal clear cell carcinoma.
    Jiang M; Lin J; Xing H; An J; Yang J; Wang B; Yu M; Zhu Y
    PeerJ; 2020; 8():e9453. PubMed ID: 32655996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of m6A-Related Signatures in the Tumor Immune Microenvironment and Identification of Clinical Prognostic Regulators in Adrenocortical Carcinoma.
    Jin Y; Wang Z; He D; Zhu Y; Hu X; Gong L; Xiao M; Chen X; Cheng Y; Cao K
    Front Immunol; 2021; 12():637933. PubMed ID: 33746977
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Ma T; Meng L; Wang X; Tian Z; Wang J; Liu X; Zhang W; Zhang Y
    Am J Transl Res; 2021; 13(10):11048-11064. PubMed ID: 34786042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MSI2 expression in adrenocortical carcinoma: Association with unfavorable prognosis and correlation with steroid and immune-related pathways.
    Veronez LC; das Chagas PF; Corrêa CAP; Baroni M; da Silva KR; Nagano LF; Borges KS; Queiroz RGP; Tone LG; Scrideli CA
    J Cell Biochem; 2021 Dec; 122(12):1925-1935. PubMed ID: 34581457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and Validation of an m6A RNA Methylation Regulators-Based Signature for Predicting the Prognosis of Adrenocortical Carcinoma.
    Shen C; Liu J; Yang X; Jiao W; Wang Y
    Front Endocrinol (Lausanne); 2021; 12():568397. PubMed ID: 33692753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of FSCN1 and FOXM1 are associated with poor prognosis of adrenocortical carcinoma patients.
    Liang J; Liu Z; Wei X; Zhou L; Tang Y; Zhou C; Wu K; Zhang F; Zhang F; Lu Y; Zhu Y
    BMC Cancer; 2019 Nov; 19(1):1165. PubMed ID: 31783819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced expression of ferroportin1 and ceruloplasmin predicts poor prognosis in adrenocortical carcinoma.
    Zhu B; Zhi Q; Xie Q; Wu X; Gao Y; Chen X; Shi L
    J Trace Elem Med Biol; 2019 Dec; 56():52-59. PubMed ID: 31442954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CENPF/CDK1 signaling pathway enhances the progression of adrenocortical carcinoma by regulating the G2/M-phase cell cycle.
    Huang YG; Li D; Wang L; Su XM; Tang XB
    J Transl Med; 2022 Feb; 20(1):78. PubMed ID: 35123514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A transcription factor signature predicts the survival of patients with adrenocortical carcinoma.
    Zhao J; Liu B; Li X
    PeerJ; 2021; 9():e12433. PubMed ID: 34966575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of a risk signature for adrenocortical carcinoma using immune-related genes.
    Fu Y; Sun S; Bi J; Kong C
    Transl Androl Urol; 2020 Oct; 9(5):1920-1930. PubMed ID: 33209656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Pan-Cancer Analysis of the Oncogenic Role of
    Yang D; Li H; Chen Y; Li C; Ren W; Huang Y
    Front Genet; 2022; 13():906174. PubMed ID: 35910232
    [No Abstract]   [Full Text] [Related]  

  • 14. Identification of prognostic genes in adrenocortical carcinoma microenvironment based on bioinformatic methods.
    Li X; Gao Y; Xu Z; Zhang Z; Zheng Y; Qi F
    Cancer Med; 2020 Feb; 9(3):1161-1172. PubMed ID: 31856409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pan-Cancer Analysis Reveals CENPI as a Potential Biomarker and Therapeutic Target in Adrenocortical Carcinoma.
    Wu F; Li G; Shen H; Huang J; Liu Z; Zhu Y; Zhong Q; Ou R; Zhang Q; Liu S
    J Inflamm Res; 2023; 16():2907-2928. PubMed ID: 37465344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and Verification of Immune-Related Genes Prognostic Signature Based on ssGSEA for Adrenocortical Carcinoma (ACC).
    Yuan K; Zeng R; Deng P; Zhang A; Liu H; Wang N; Tang Y; Yin Z; Liu H
    Int J Gen Med; 2022; 15():1471-1483. PubMed ID: 35210821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression profiles analysis identifies the values of carcinogenesis and the prognostic prediction of three genes in adrenocortical carcinoma.
    Gao Z; Man X; Li Z; Bi J; Liu X; Li Z; Zhu Y; Zhang Z; Kong C
    Oncol Rep; 2019 Apr; 41(4):2440-2452. PubMed ID: 30816525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of RUNX1 in clear cell renal cell carcinoma predicts poor prognosis.
    Fu Y; Sun S; Man X; Kong C
    PeerJ; 2019; 7():e7854. PubMed ID: 31592165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a Ferroptosis-Related Signature Associated with Prognosis and Immune Infiltration in Adrenocortical Carcinoma.
    Chen X; Yan L; Jiang F; Lu Y; Zeng N; Yang S; Ma X
    Int J Endocrinol; 2021; 2021():4654302. PubMed ID: 34335745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Role of Ki-67 in Adrenocortical Carcinoma After Primary Resection: A Retrospective Mono-Institutional Study.
    Zhang F; Zhang F; Liu Z; Wu K; Zhu Y; Lu Y
    Adv Ther; 2019 Oct; 36(10):2756-2768. PubMed ID: 31471770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.